Epidermal growth factor receptor (EGFR) is a protein on the surface of your cells that helps them grow. When the gene that codes for EGFR has a mutation, it affects the way this protein works ...

These drug treatments won't cure your lung cancer, but they can help you manage the disease and stave off serious symptoms. Epidermal growth factor receptor (EGFR) is a protein present on the surface ...

EGFR, epidermal growth factor receptor, is a protein found on the surface of your cells that makes them grow. If you have non-small-cell lung cancer (NSCLC), your cancer might carry certain ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...

Clinical Development Initiated in Greater China by Partner Betta PharmaceuticalsWATERTOWN, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company ...

Introduction: We developed and produced a new series of 4,6-diaryl-pyrimidines 9–29 as antiproliferative agents targeting EGFR/VEGFR-2. Methods: The antiproliferative efficacy of the novel targets was ...

November is Lung Cancer Awareness Month, and early detection is in the air. According to the Centers for Disease Control, ...

Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.

The current standard treatment, tyrosine kinase inhibitors (TKIs), targets the mutant EGFR protein but often encounters ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Similarly, a mutation in the gene responsible for the EGFR protein triggers cell proliferation – in both cases the massive ...